InMed Pharmaceuticals Inc. Quarterly Return On Equity in % from Q2 2020 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q2 2020 to Q4 2023.
  • InMed Pharmaceuticals Inc. Return On Equity for the quarter ending December 31, 2023 was -91.8 %, a 38.7% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2023 was -63.8 %, a 57.7% increase from 2022.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2022 was -151 %, a 10.4% decline from 2021.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2021 was -137 %, a 30% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -91.8 +57.9 +38.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -95.4 +74.2 +43.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -63.8 +86.9 +57.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -132 -14.9 -12.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -150 -34.3 -29.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -170 -55.6 -48.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -151 -14.1 -10.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -117 +3.24 +2.69% Jan 1, 2022 Mar 31, 2022
Q4 2021 -115 +4.13 +3.45% Oct 1, 2021 Dec 31, 2021
Q3 2021 -114 +0.29 +0.25% Jul 1, 2021 Sep 30, 2021
Q2 2021 -137 -31.5 -30% Apr 1, 2021 Jun 30, 2021
Q1 2021 -121 Jan 1, 2021 Mar 31, 2021
Q4 2020 -120 Oct 1, 2020 Dec 31, 2020
Q3 2020 -114 Jul 1, 2020 Sep 30, 2020
Q2 2020 -105 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.